Indications
Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Angioimmunoblastic T-Cell Lymphoma
Arvinas Inc.
P1
CC
(43)
Immunoglobulin G1 [188,412-Bis[4-(Azidomethyl)-L-Phenylalanine]], Anti-(Human Folate Receptor ?) (Human-Mus Musculus Monoclonal Sp8166 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Sp8166 ?-Chain, Dimer, Click Reaction Product With 3-[[[[4-[[N-[4-(11,12-Didehydrodibenz[B,F]Azocin-5(6H)-Yl)-1,4-Dioxobutyl]-L-Valyl-N5-(Aminocarbonyl)-L-Ornithyl]Amino]Phenyl]Methoxy]Carbonyl]Amino]-N,?,?-Trimethyl-L-Phenylalanyl-N-[(1S,2E)-3-Carboxy-1-(1-Methylethyl)-2-Buten-1-Yl]-N,3-Dimethyl-L-Valinamide (1:4)
Ovarian Carcinoma
Sutro Biopharma, Inc.
P1
CC
(43)
Immunoglobulin G1 [188,412-Bis[4-(Azidomethyl)-L-Phenylalanine]], Anti-(Human Folate Receptor ?) (Human-Mus Musculus Monoclonal Sp8166 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Sp8166 ?-Chain, Dimer, Click Reaction Product With 3-[[[[4-[[N-[4-(11,12-Didehydrodibenz[B,F]Azocin-5(6H)-Yl)-1,4-Dioxobutyl]-L-Valyl-N5-(Aminocarbonyl)-L-Ornithyl]Amino]Phenyl]Methoxy]Carbonyl]Amino]-N,?,?-Trimethyl-L-Phenylalanyl-N-[(1S,2E)-3-Carboxy-1-(1-Methylethyl)-2-Buten-1-Yl]-N,3-Dimethyl-L-Valinamide (1:4)
Primary Peritoneal Carcinoma
Sutro Biopharma, Inc.
P1
CC
(43)
Immunoglobulin G1 [301-Alanine,De-C-Terminal-Lysine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Inca00186 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Inca00186 ?-Chain, Dimer
Digestive System Neoplasm
Incyte Corporation
P1
CC
(43)
Immunoglobulin G1 [301-Alanine,De-C-Terminal-Lysine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Inca00186 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Inca00186 ?-Chain, Dimer
Head And Neck Squamous Cell Carcinoma
Incyte Corporation
P1
CC
(43)
Immunoglobulin G1 [351-Alanine,386-Alanine,387-Alanine] Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Imm2902 ?1-Chain), Disulfide With 1-125-Signal Regulatory Protein ? [80-Alanine] (Human Isoform 4 Variant) Fusion Protein With Peptide Linker ((Ggggs)3) Fusion Protein With Human-Mus Musculus Monoclonal Imm2902 ?-Chain, Dimer
Gastric Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
P1
CC
(43)
Immunoglobulin G1, Anti-(Human Tissue Factor Pathway Inhibitor) (Human Monoclonal Pf-06741086 .Gamma.1-Chain), Disulfide With Human Monoclonal Pf-06741086 .Lambda.-Chain, Dimer
Severe Hemophilia A
Pfizer
P1
CC
(43)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Alveolar Soft Part Sarcoma
Taiho Pharmaceutical Co., Ltd.
P1
CC
(43)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Skin Cancer
Toray Industries, Inc
P1
CC
(43)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Gastric Neoplasm
Elevation Oncology
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Esophageal Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Head And Neck Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Hepatocellular Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Ovarian Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Soft Tissue Sarcoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Esophageal Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Head And Neck Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Hepatocellular Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Ovarian Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Soft Tissue Sarcoma
M.D. Anderson Cancer Center
P1
CC
(43)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Digestive System Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
CC
(43)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Metastatic Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.
P1
CC
(43)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Squamous Cell Carcinoma
Bicara Therapeutics
P1
CC
(43)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Anal Canal Squamous Cell Carcinoma
Bicara Therapeutics
P1
CC
(43)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Squamous Cell Lung Carcinoma
Bicara Therapeutics
P1
CC
(43)
Showing 2451 to 2475 of 9,928 assets
Previous
Page 99 of 398
Next